Currently out of the existing stock ratings of David Adlington, 33 are a HOLD (47.14%), 19 are a BUY (27.14%), 18 are a SELL (25.71%).

David Adlington

Work Performance Price Targets & Ratings Chart

Analyst David Adlington, currently employed at JPMORGAN, carries an average stock price target met ratio of 40.4% that have a potential upside of 36.69% achieved within 233 days.

David Adlington’s has documented 135 price targets and ratings displayed on 8 stocks. The coverage is on Healthcare, Communication Services sectors.

Most recent stock forecast was given on FMS, Fresenius Medical Care at 06-Nov-2024.

Wall Street Analyst David Adlington

Analyst best performing recommendations are on AMFPF (AMPLIFON S.P.A).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 10/19/2021. The price target of $42.31 was fulfilled within 3 days with a profit of $2.5 (6.28%) receiving and performance score of 20.93.

Average potential price target upside

of $14.69 (40.29%) on SNN (SMITH & NEPHEW SNATS).
of $5.04 (32.88%) on FMS (FRESENIUS MEDICAL CARE).
of $3.81 (11.89%) on PHG (KONINKLIJKE PHILIPS NV ADR).

FMS Fresenius Medical Care PHG Koninklijke Philips NV ADR SE Sea Ltd SNN Smith & Nephew SNATS FSNUY Fresenius SE KGaA ADR SMMNY Siemens Healthineers AG ADR ALC Alcon AG AMFPF Amplifon S.p.A

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

David Macdonald (TRUIST)